If you sign up for the free OncologySTAT news service (provided by Elsevier and based on their publications), you can then read the interview with James Eastham of Memorial Sloan-Kettering Cancer Center on the pros and cons of screening (as opposed to individual testing) for prostate cancer. Dr. Eastham is currently involved in the development of new guidelines on prostate cancer screening being developed by the National Comprehensive Cancer Network (NCCN).
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, testing


Search for new and
ongoing trials on the
CTAG PCa web site
